SIR 2025
Interventional Oncology
Scientific Session
Ali Montazeri, MD, MPH
Radiology Resident
Mayo Clinic Florida, United States
Claudia R. Silver, BS
Medical Student
Florida State University College of Medicine, United States
Cynthia De La Garza Ramos, MD
Interventional Radiology Resident
Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States, United States
Andrew R. Lewis, MD
Assistant Professor
Mayo Clinic Florida, United States
Ricardo Paz-Fumagalli, MD
Interventional Radiologist
Mayo Clinic Florida, United States
Gregory T. Frey, MD MPH
Assistant Professor
Mayo Clinic, United States
Beau B. Toskich, MD, FSIR
Professor
Department of Radiology, Division of Interventional Radiology, Mayo Clinic, Jacksonville, FL 32224, United States, United States
To determine authorized user parameters predictive of complete pathologic necrosis (CPN) in hepatocellular carcinoma (HCC) treated with radiation segmentectomy (RS).
Materials and Methods:
A single institution, retrospective, post-treatment Bremsstrahlung SPECT CT voxel-based dosimetry analysis of 61 tumors treated with RS as a subset from a previously published cohort (1) was performed using Simplicit90Y software (Boston Scientific). Specific activity (SA) was defined per an updated glass microsphere (TheraSphere, Boston Scientific) estimation (2). ROC curves and Mann-Whitney U tests were performed using SPSS v.28 with significance set at < 0.05.
Results: Median SA (1242 vs 867 Bq, p=0.018), tumor dose (1086 vs 738 Gy, p=0.007), angiosome normal parenchyma dose (490 vs 309 Gy, p=0.005), and total angiosome dose (577 vs 352 Gy, p=0.005) were higher in the CPN (n=43) vs non-CPN (n=18) cohort. ROC analysis (AUC, Sensitivity, Specificity) demonstrated that an SA ≥ 570 Bq (0.69, 88%, 50%), tumor dose ≥ 844 Gy (0.72, 76%, 67%), angiosome normal parenchymal dose ≥ 420 Gy (0.73, 60%, 78%), and total angiosome dose ≥ 439 Gy (0.73, 70%, 67%) were predictive of CPN (p< 0.05). No statistical difference was noted between the tumor or angiosome particle densities, tumor volume, or angiosome volumes in the CPN and non-CPN cohort.
Subgroup ROC analysis of tumors that received SA < 570 Bq (n=15), a tumor dose ≥451 Gy (0.83, 100%, 67%), and total angiosome dose ≥ 263 Gy (0.85, 83%, 89%) were predictive of CPN (p< 0.05). An average angiosome particle density ≥ 11.4 k/ml (0.81, 83%, 79%) was 83% sensitive and 79% specific to predict CPN in this subgroup (p< 0.05). There were no statistically significant independent predictors of CPN in patients who were treated with SA≥570 Bq.
Eighty-eight percent of tumors that met all treatment thresholds achieved CPN (n=23/26) vs 0% that did not meet a single threshold (n=0/7).
Conclusion:
Higher specific activity, tumor dose, angiosome normal parenchymal dose, and total angiosome dose were predictive of CPN. Particle density was only predictive of CPN in tumors treated with SA< 570 Bq. There were no independent predictors of CPN in tumors treated using SA≥ 570 Bq. CPN was achieved in 88% of tumors that met all treatment thresholds and in none that did not meet any threshold.